Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Skinvisible, a developer of patented polymer delivery vehicles, and Cambrex, a life sciences company, have signed a joint marketing and development agreement.
Subscribe to our email newsletter
The agreement provides for R&D into acne formulations based on Skinvisible’s Invisicare technology and benzoyl peroxide (BPO) manufactured by Cambrex. In addition, the two companies will share marketing responsibilities for the products that are developed under this agreement.
Steve Klosk, president and CEO of Cambrex, said: “This collaboration with Skinvisible will enable us to provide our clients with technology-enhanced delivery options for our BPO products.
“We are excited to have the opportunity to associate our active pharmaceutical ingredients with Skinvisible’s innovative technology. We foresee that this value-added approach is an advantage for our clients and acne patients.”